Bret Scholtes acted as the CEO and President of Guardion Health Sciences from January 2021 until June 2023. He came with a solid background in finance, armed with an MBA from New York University and an accounting degree from the...
Bret Scholtes acted as the CEO and President of Guardion Health Sciences from January 2021 until June 2023. He came with a solid background in finance, armed with an MBA from New York University and an accounting degree from the University of Missouri. Before Guardion, he led Omega Protein Corporation for nearly a decade, building his skills in corporate development and finance. Scholtes wasn't just leading from behind; he made a significant mark with his hands-on approach to executive role, focusing on performance and company growth. His compensation saw a wild swing, from earning nearly $1.68 million in 2021 to just $411,000 in 2022, showing how quickly situations can change in the corporate world. Interestingly, he was on the insider trading radar, with notable trades starting from January 2021 through 2024, indicating his deep involvement with the company's stock. Overall, his transition represents the typical roller coaster of executive positions in companies facing challenges and opportunities.